Latest News in the pharma Industry

The cost of bringing US pharma manufacturing home

23 Apr 2021

What are the major implications of any drive to reshore US pharmaceutical manufacturing, given that current Asian domination is based on cost savings and capacity? We ask the experts...

FDA inspection report slams Emergent for quality and cleanliness breaches at Bayview facility

22 Apr 2021

Company failed to investigate vaccine drug substance discrepancies thoroughly, says US regulator

CPhI Discover: Two-Tier Contract Market in China as Top CDMOs Grab all the Growth

21 Apr 2021

Ahead of CPhI Discover (17-28 May, 2021) - global pharma's largest ever virtual gathering - we spoke to CPhI Annual Report expert Vicky Xia, China Head at BioPlan Associates on the biologics trends she is seeing emerging in the contract services sp...

EU secures additional 100 million doses of Pfizer-BioNTech vaccine for 2021 delivery

19 Apr 2021

Extra supply will bring total number of doses scheduled to be shipped to EU this year to 600 million

Abzena to build US biologics manufacturing plant in North Carolina

16 Apr 2021

New facility will be research partnering company’s sixth global site and will be dedicated to mammalian biologics

CPhI Japan open for business!

14 Apr 2021

Informa Markets' first in-person trade show of the year welcomes attendees in Tokyo as face-to-face interaction recommences among pharma community

Origin Pharma Packaging opens new UK warehouse in significant capacity expansion

25 Mar 2021

New site includes warehouse maagement system which packaging firm claims will increase picking accuracy and efficiency

Pharma importers forced to reorganise supply chains due to Brexit complications, says medicines trade expert

18 Mar 2021

EU/UK trade deal fell way short of UK’s initial expectations for medicinal products ahead of negotiations, says Peter Gough at NSF International

Pfizer to sell Chinese biologics manufacturing facility to WuXi

17 Mar 2021

Multinational makes ‘difficult decision’ to halt presence in Chinese biosimilars market five years after $350 million investment

Adaptive clinical trial success calls for flexible approach

15 Mar 2021

Adaptive clinical trials have accelerated COVID-19 vaccine development and could make drug R&D more efficient but running such studies is complex and challenging and sponsors need to prepare, say experts

Pharma manufacturing going digital in bid for quality and efficiency

22 Feb 2021

Digitalisation is finally coming to pharma with more drug manufacturers using industry 4.0 tech to monitor, model and control production processes.

Novavax agrees huge supply deal with Gavi for 1.1 billion doses of COVID-19 vaccine

19 Feb 2021

Biotech will manufacture shots with partner SII for equitable vaccine distribution programme, COVAX